Search Results
Videos
Impact of COVID-19 on the Existing Elimination Programs - John Ward
Presented at:
Conference on Liver Disease in Africa (COLDA) 2020
Slidesets
Viral dynamics and factors favouring the duration of covid-19 positivity: Evidence from the first-three epidemiological waves in Cameroon - Aurelie Minelle Kengni Ngueko
Presented at:
Approaches to Combat COVID-19 in Low- and Middle-Income Countries Workshop 2022
Videos
Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience – Part 2 | Fiona Marra, MPharm, MSc
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022
Videos
Case-Based Discussion of Oral Antivirals for COVID-19: Learning from Experience - Part 1 | Catia Marzolini, PharmD, PhD
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022
Videos
Oral Antivirals for COVID-19: How to Best Make Use of Their Therapeutic Effects | Giovanni Di Perri, MD, PhD
Presented at:
Course on Clinical Pharmacology of SARS-CoV-2 Antivirals 2022
Slidesets
Starting Long-Acting Drugs in the COVID-19 Era - Anton Pozniak, MD, FRCP
Presented at:
Global HIV Clinical Forum 2020
Slidesets
HIV and COVID-19 Stigma and Discrimination, History Repeating Itself -Tanat Chinbunchorn, MD
Presented at:
APACC 2020
Slidesets
Disruption of HIV Prevention Services During COVID Response in Bangkok -Thanyawee Puthanakit, MD
Presented at:
APACC 2020
Slidesets
The Role of Pharmacology in Selection of COVID-19 Candidates - Andrew Owen, PhD, FRSB, FBPhS, FLSW
Presented at:
International Workshop on Clinical Pharmacology on HIV, Hepatitis and Other Antiviral Drugs 2020